What Are The Strategic Insights Behind The Gouty Arthritis Market Expansion To $4.8 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Current Size And Growth Outlook For The Gouty Arthritis Market?
In recent times, the market size for gouty arthritis has seen significant expansion. With a compound annual growth rate (CAGR) of 7.3%, it is projected to increase from $3.44 billion in 2024 to $3.69 billion in 2025. Factors contributing to this growth in the historical period include the prevalent increase in chronic diseases, heightened alcohol consumption, the rise in the older population, wider acknowledgment of improved regenerative therapies, and escalating healthcare spending.
Forecasted robust expansion is on the horizon for the gouty arthritis market in the upcoming years, with projections reaching $4.8 billion by 2029, an impressive compound annual growth rate (CAGR) of 6.8%. This predicted expansion during the forecasted time frame is linked to enhanced healthcare infrastructure, a rise in obesity rates, a surge in gout incidents, and heightened public awareness. The forecast period also points to significant trends such as an increased demand for successful treatment methods, innovations in regenerative therapies, advancements in technology, product introductions, and regulatory authorizations.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp
What Core Drivers Are Expected To Influence The Gouty Arthritis Market?
The surging instances of obesity are anticipated to boost the expansion of the gouty arthritis market. Obesity, a health condition typified by abnormal fat accumulation that endangers a person’s well-being, is usually gauged through the body mass index (BMI). The obesity prevalence is escalating due to increased intake of calorie-rich, processed foods, and inactive lifestyles. Obesity triggers gouty arthritis by pushing up uric acid production and suppressing the body’s capacity to remove it. This consequently results in uric acid crystal buildup in the joints. Moreover, surplus body weight heaps additional pressure on joints, aggravating the swelling and discomfort linked to gout. For example, the World Health Organization, a Switzerland-based United Nations agency tasked with global public health, noted in March 2022 that around 1 billion people, encompassing 650 million adults, 340 million teenagers, and 39 million children, were classified as obese. This number is persistently on the rise. Projections estimate that by 2025, roughly 167 million adults and children will be grappling with health issues due to overweight. Thus, the escalating instance of obesity is fuelling the growth of the gouty arthritis market.
Which Segmentation Categories Are Highlighted In The Gouty Arthritis Market Analysis?
The gouty arthritismarket covered in this report is segmented –
1) By Type: Acute Gouty Arthritis; Chronic Gouty Arthritis
2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Pain Reliever; Corticosteroids; Xanthine Oxidase Inhibitors; Uricosurics; Others Treatments
3) By Diagnosis: Joint Fluid Test; Blood Test; X-Ray Imaging; Ultrasound; Dual Energy Computed Tomography (CT) Scan; Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Others Distribution Channels
5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout; Acute Gout Attack (Intermittent Flares); Severe Acute Gout With Joint Deformities
2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits); Chronic Gout With Joint Damage; Chronic Gout With Renal Complications; Chronic Gout With Comorbidities (Hypertension, Diabetes)
Which Market Trends Are Expected To Define The Future Of The Gouty Arthritis Market?
Leading businesses in the gouty arthritis market are amplifying their efforts to create innovative products like Cortrophin gel, to offer better and more specific treatments for the ailment. Cortrophin Gel, or repository corticotropin injection as it’s also known, is a purified version of the adrenocorticotropic hormone (ACTH). It’s used to deal with numerous inflammatory and autoimmune conditions and these include gouty arthritis. In October 2023 for example, a US-based pharmaceutical firm known as ANI Pharmaceuticals got the approval from the Food and Drug Administration and released a new 1-mL vial size of Purified Cortrophin Gel. The product is designed for aiding in the treatment of some patients who are experiencing severe gouty arthritis attacks. Currently, the only adrenocorticotropic hormone (ACTH) therapy that has been approved by the FDA for treating eligible patients suffering from acute gouty arthritis flare-ups is Cortrophin Gel.
Who Are The Dominant Players In The Gouty Arthritis Market Today?
Major companies operating in the gouty arthritis market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol Myers Squibb, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report
Which Regional Markets Are Emerging As Key Hubs For The Gouty Arthritis Market?
North America was the largest region in the gouty arthritis market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=16070&type=smp
Browse Through More Reports Similar to the Global Gouty Arthritis Market 2025, By The Business Research Company
Arthritis Monoclonal Antibodie Global Market Report 2025
Psoriatic Arthritis Treatments Global Market Report 2025
Companion Animal Arthritis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
